Otolaryngology, Respiratory, and Allergic
Allergic Rhinitis
February 2003
Clinical Focus*
- How do currently available clinical treatments for allergic rhinitis affect costs and work performance?
- What is the relationship between symptom outcomes or disease-specific quality-of-life measures and work performance among adults with allergic rhinitis? Can data on symptomatic outcome or quality of life be reliably translated into work performance measures?
- How effective are (a) environmental measures, (b) immunotherapy, and (c) combined treatments, such as antihistamines and nasal steroids or antihistamines and oral decongestants, for relief of symptoms in adults with allergic rhinitis?
- How do different types of health care providers (generalists, allergy specialists, and otolaryngologists) treat adults with allergic rhinitis, and how do treatment outcomes vary by provider?
- In adult patients with symptoms of allergic rhinitis, does the prevalence, treatment patterns, or response to treatment vary according to a patient's race or ethnicity?
*Addressed in the summary or evidence report.
Management of Allergic Rhinitis in the Working-Age Population
Summary (Publication No. 03-E013, February 2003)
Evidence Report (AHRQ Publication No. 03-E015, March 2003)
(PDF Files; File Download)
EPC: Duke University
Topic Nominator: American Association of Health Plans
Return to Quick Menu: Evidence Report Topics
Return to Evidence-based Practice